Sign in Pull a receipt

ELTX

Elicio Therapeutics, Inc.

Healthcare · Biotechnology

$104.92 sample

-1.21 (-1.14%) 1D

Market cap

$180.1B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-15

Alerts

8

Price$104.92 +11.16% 3M daily closessample

108.3693.20

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: EVP, Operations
Oct 15SEC10-Q filed
Oct 09INSInsider buy: Chief Executive Officer
Oct 06SEC8-K filed: material event
Sep 30SEC8-K filed: material event
Sep 22INSInsider sell: Chief Financial Officer
Sep 15INSInsider sell: Director
Sep 04INSInsider sell: General Counsel

Sign up to see the real ELTX record →

Company facts

SEC EDGAR registration

Name: Elicio Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -25sample, -100 to +100
Reporting currency: USD

Who is positioning in ELTX

sample

Insiders: 15 insider transactions over 90 days, net selling, $150.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 22 funds hold $1.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.2B +19.1% y/y

Q4 2024Q3 2026

Inventory$3.6B +9.6% y/y

Q4 2024Q3 2026

Accounts receivable$2.7B +9.3% y/y

Q4 2024Q3 2026

Total debt$7.5B +17.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $120.6B +7.6% 3M
Sample peer B: $79.2B +14.2% 3M
Sample peer C: $89.8B -8.5% 3M
Sample peer D: $91.7B -13.4% 3M
Sample peer E: $28.4B +4.4% 3M